SCHEMBL5524548

SCHEMBL5524548

CCC(OC(N)=O)C(=O)c1noc(-c2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 4/20 0.49
HDAC1 Q13547 3/20 0.49
HDAC8 Q9BY41 2/20 0.49
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 1/20 0.40
NOTUM Q6P988 1/20 0.40
MAPT P10636 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PPARG P37231 2/20 0.39
PPARA Q07869 2/20 0.39
PPARD Q03181 1/20 0.39
NR1H4 Q96RI1 3/20 0.38
SMPD1 P17405 2/20 0.37
S1PR1 P21453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5524543 1.00 HDAC6 (0.49) HDAC6HDAC1HDAC8ALDH1A1KMT2A
SCHEMBL5954867 0.81 HDAC6 (0.55) HDAC6HDAC1HDAC8ALDH1A1KMT2A
SCHEMBL6206620 0.81 HDAC6 (0.55) HDAC6HDAC1HDAC8ALDH1A1KMT2A
SCHEMBL5527591 0.77 KDM4E (0.30) KDM4EHSD17B10
SCHEMBL5527583 0.77 KDM4E (0.30) KDM4EHSD17B10
SCHEMBL14427046 0.74 HDAC6 (0.53) HDAC6HDAC1HDAC8ALDH1A1KMT2A
SCHEMBL18606702 0.74 HDAC1 (0.68) HDAC6HDAC1HDAC8ALDH1A1KMT2A
SCHEMBL5528930 0.73 HDAC4 (0.39) HDAC6HDAC1HDAC8
SCHEMBL5528921 0.73 HDAC4 (0.39) HDAC6HDAC1HDAC8
SCHEMBL14389891 0.73 HDAC6 (0.62) HDAC6HDAC1HDAC8ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1744755-B1 COMPOUNDS AND COMPOSITIONS AS CATHEPSIN S INHIBITORS IRM LLC (BM) 2012-12-05 EP claimed
US-20070232606-A1 Compounds and Compositions as Cathepsin S Inhibitors IRM LLC (BM) 2007-10-04 US claimed
EP-1744755-B1 COMPOUNDS AND COMPOSITIONS AS CATHEPSIN S INHIBITORS IRM LLC (BM) 2012-12-05 EP disclosed
US-20070232606-A1 Compounds and Compositions as Cathepsin S Inhibitors IRM LLC (BM) 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232606-A1 Compounds and Compositions as Cathepsin S Inhibitors CTSS, CTSB, CTSF HDAC6 120/4885HDAC1 256/4885HDAC8 401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.